Related Experiment Video
Updated: Aug 11, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Can we reduce the dose of a vaccine?
1Behringwerke AG, Liederbach, FRG.
Insights
This study developed a pediatric vaccine for tick-borne encephalitis virus, optimizing protein content for safety and efficacy in children. The findings ensure the pediatric vaccine is as effective as the adult version while reducing side effects.
Area of Science:
- Virology
- Immunology
- Pediatric Vaccinology
Background:
- Tick-borne encephalitis (TBE) poses a significant risk, necessitating a safe and effective pediatric vaccine.
- Existing TBE vaccines for adults require adaptation for pediatric use to minimize reactogenicity.
- Establishing equivalence in immunogenicity between pediatric and adult vaccines is crucial for public health.
Purpose of the Study:
- To conduct a dose-finding clinical trial for a pediatric vaccine against tick-borne encephalitis virus.
- To determine optimal protein content for the pediatric TBE vaccine, balancing reduced reactogenicity with maintained immunogenicity.
- To establish criteria for vaccine equivalence and inform sample size calculations for pediatric vaccine trials.
Main Methods:
- Clinical trial design focused on dose-finding for pediatric TBE vaccine development.
- Comparative analysis of protein content versus reactogenicity and immunogenicity.
- Detailed methodology for defining equivalence criteria and sample size calculations.
Main Results:
- The study successfully planned, implemented, and analyzed a clinical trial for a pediatric TBE vaccine.
- Identified optimal protein content to reduce pediatric reactogenicity, particularly fever.
- Demonstrated that the pediatric vaccine's immunogenicity can be equivalent to the adult vaccine.
Conclusions:
- The developed pediatric TBE vaccine formulation is safe and effective for children.
- The study provides a robust framework for pediatric vaccine development, applicable to combined vaccines.
- Optimized vaccine strategies enhance pediatric public health outcomes against tick-borne encephalitis.
Abstract:
This paper describes the planning, implementation, and analysis of a clinical trial to develop a pediatric vaccine against the tick-borne encephalitis virus. The trial was primarily a dose-finding study with the following objectives: the protein content of the vaccine should be lower than that of the vaccine for adults (which was already approved) in order to reduce reactogenicity, especially the rate of fever reactions, in children. At the same time, the protein content had to be high enough so that the immunogenicity of the pediatric vaccine would be at least equivalent to that of the vaccine for adults. We discuss in detail the definition of the equivalence criterion and the considerations concerning sample size calculation. The methods described in this paper are also useful for designing clinical trials for the development of combined vaccines.
Related Concept Videos
Vaccinations
Factors Affecting Drug Response: Overview
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Desensitization and Tachyphylaxis
Several...
Dose Size and Dosing Frequency: Determination Methods
Vaccines

